Clinical characteristics | Mirena group (n = 25) | Metformin group (n = 25) | Test value | p-value |
---|---|---|---|---|
Age (years) | 51.61 ± 3.08 | 51.13 ± 2.59 | 221.5 | 0.34a |
Chronic illness | ||||
Absent | 12 (48%) | 8 (32%) | 1.46 | 0.23b |
Present | 13 (52%) | 17 (68%) | ||
Hypertension | 3 (12%) | 8 (32%) | ||
Diabetes | 9 (36%) | 3 (12%) | ||
Asthma | 2 (8%) | 7 (28%) | ||
Menopausal status | ||||
Perimenopausal | 8 (32%) | 13 (52%) | 2.24 | 0.13b |
Postmenopausal | 17 (68%) | 12 (48%) | ||
Menopausal yearsc(n = 16) | ||||
Mean ± SD | 3.06 ± 1.34 | 2.82 ± 1.6 | 80 | 0.68a |
median (range) | 3 (1 – 5) | 3 (1 – 5) | ||
Parity | 3.52 ± 1.34 | 3.87 ± 1.1 | 218 | 0.29a |
History of delivery | ||||
Vaginal only | 17 (68%) | 19 (76%) | 2.11 | 0.34a |
Caesarian only | 4 (16%) | 1 (4%) | ||
Both | 4 (16%) | 5 (20%) | ||
BMI (kg/m2), mean ± SD | 36.31 ± 1.33 | 36.98 ± 1.85 | 225.5 | 0.389a |